Skip to main content
Caplight Logo









MillionMolecules

MillionMolecules

Private
FreiburgHealthcare & Life Scienceshttps://millionmolecules.de/

Last Round

Grant

Jan 16, 2025

Total Funding Raised

$920,000

Company Overview

MillionMolecules is a life science company developing an innovative digital PCR (dPCR) system based on centrifugal microfluidics for the precise quantification of biomolecules.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

digital PCRdPCRcentrifugal microfluidicsmolecular diagnosticslab-on-a-chipquantitative PCRqPCRbiomolecule quantificationlaboratory instrumentationbiotech hardwarehigh-throughput diagnosticsDNA quantificationRNA quantificationautomated lab equipmentlife science tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MillionMolecules Comparables

Compare MillionMolecules with similar companies based on industry and business-model similarity.

MillionMolecules comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
JN Medsys
82%
Countable Labs
80%
RainSure Scientific
79%

MillionMolecules Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 16, 2025

Key People

Founding team and executive leadership

Judith Schlanderer

Co-Founder & COO

Founding Team

MillionMolecules Investors

Notable investors and investment history

MillionMolecules investors
InvestorRounds
Federal Ministry for Economic Affairs and EnergyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 18, 2026

    Grew 60% QoQ from 5 to 8 employees.

  • Jan 16, 2025

    $920K grant received from the Federal Ministry for Economic Affairs and Energy.

MillionMolecules Filings

Explore SEC and related filing metadata, where available.

MillionMolecules filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MillionMolecules's valuation, stock price, and market status.

Is MillionMolecules a public or private company?

MillionMolecules is a private company.

What is the current stock price of MillionMolecules?

MillionMolecules is a private company with no public stock price. Caplight tracks MillionMolecules's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is MillionMolecules worth (valuation)?

Valuation information for MillionMolecules is not publicly available.

Can I buy MillionMolecules stock?

MillionMolecules shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MillionMolecules's last funding round?

MillionMolecules's most recent funding round was Grant on January 16, 2025.

Who are the main investors in MillionMolecules?

Key investors in MillionMolecules include Federal Ministry for Economic Affairs and Energy.

Will MillionMolecules IPO soon?

No public IPO plans have been announced for MillionMolecules.

How can I track MillionMolecules secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MillionMolecules's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFreiburg
Employee Range7
Year Founded2025
Last FundingJan 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?